PD15-07 7-gene predictive biosignature improves risk stratification for breast ductal carcinoma in situ patients compared to clinicopathologic criteria, identifying a low risk group not clinically benefiting from adjuvant radiotherapy

This article has no abstract
Epistemonikos ID: f76cb629ee92b9d27cf007697471d99fe9a1ddcd
First added on: Feb 15, 2025